Am J Transplant, Volume 22, Suppl 3 Archives - Page 34 of 190 - ATC Abstracts

2022 American Transplant Congress
Tacrolimus Exposure Estimation in Stable Kidney Transplant Recipients Using Maximum A Posteriori Bayesian Approach
T. Nguyen¹, N. M. Smith¹, K. Attwood², B. Murray³, K. Tornatore-Morse¹
¹University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, ²School of Public Health; University at Buffalo, Buffalo, NY, ³Erie County Medical Center; School of Medicine/UB, Buffalo, NY
*Purpose: Tacrolimus exhibits interpatient pharmacokinetic variability that impacts clinical responses and requires routine trough therapeutic drug monitoring. Tacrolimus troughs do not consistently predict area under…
2022 American Transplant Congress
Augmented Reality in Hand-Assisted Retroperitoneal Donor Nephrectomy – Procedure Step Adjusted Evaluation for the Surgeons’ Benefits
R. Wahba¹, L. Krames², J. Hogervorst³, R. R. Datta¹, M. N. Thomas¹, P. Suppa³, D. L. Stippel¹
¹Department of General, Visceral, Cancer and Transplantation Surgery, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Köln, Germany, ²Karlsruhe Institute of Technology, Institute of Biomedical Engineering (IBT), Karlsruhe, Germany, ³Olympus Surgical Technologies Europe, Hamburg, Germany
*Purpose: To identify procedure steps where a patient-specific CT-reconstructed virtual 3D model of the kidney displayed on the screen can support the surgeon while performing…
2022 American Transplant Congress
Variable Course of Hepatitis A Virus Infection in Solid Organ Transplant Recipients
A. Vostal¹, J. Husson², A. Shishido¹, N. Jakhete³, E. Moore⁴, X. Wen⁵, A. Amoroso², R. Meier⁶, E. Wilson², K. K. Saharia²
¹Div. of Infectious Diseases, Univ. of Maryland Medical Center, Baltimore, MD, ²Div. of Infectious Diseases, Univ. of Maryland School of Medicine and Institute of Human Virology, Baltimore, MD, ³Div. of Hepatology, Univ. of Maryland School of Medicine, Baltimore, MD, ⁴Dept of Surgery, Brooklyn Hospital Center, Brooklyn, NY, ⁵Dept. of Surgery, Univ. of Florida, Gainesville, FL, ⁶Dept. of Surgery, Univ. of Maryland School of Medicine, Baltimore, MD
*Purpose: Although Hepatitis A virus (HAV) infection is typically a self-limited disease in immunocompetent individuals, the natural history and viral kinetics of HAV in solid…
2022 American Transplant Congress
One Nuclei at a Time: Decoding Kidney Allograft Fibrosis by Single Nuclei RNA-Sequencing
J. McDaniels¹, A. Shetty¹, C. Kuscu², C. Kuscu², E. Bhardi¹, T. Rousselle¹, C. Drachenberg³, M. Talwar⁴, J. Eason⁵, T. Muthukumar⁶, D. Maluf¹, V. Mas¹
¹University of Maryland, Baltimore, Baltimore, MD, ²University of Tennessee Health Science Center, Memphis, TN, ³University of Maryland, Baltimore, MD, ⁴UTHSC, memphis, TN, ⁵University of Tennessee/Methodist Transplant Institute, Memphis, TN, ⁶Weill Cornell Medicine, New York, NY
*Purpose: The biological mechanisms underpinning late graft loss due to chronic allograft dysfunction remain unknown. Single nuclei RNA-sequencing (snRNAseq) of healthy and fibrotic kidney grafts…
2022 American Transplant Congress
Financial Impact of Adult Kidney Transplant MS-DRGs 650, 651 and 652 in U.S. Transplant Hospitals
E. Zavala¹, J. Rogers², H. Buschmann¹, S. Rath¹, S. Karp¹
¹VUMC, Nashville, TN, ²Transplant Management Group, San Diego, CA
*Purpose: The Medicare Hospital Inpatient Prospective Payment System (IPPS) permits each inpatient admission to be categorized into a diagnosis-related group (DRG). DRGs can be further…
2022 American Transplant Congress
Preemptive Therapy in Cytomegalovirus (CMV) Seropositive Donor to Seronegative Recipient Liver Transplants
J. Revollo, E. Aldag, K. Cooper, B. Noell, V. Casingal, K. Gajurel
Transplant, Atrium Health's Carolinas Medical Center, Charlotte, NC
*Purpose: To evaluate if a preemptive therapy strategy can prevent CMV disease and induce CMV seroconversion.*Methods: Observational data collection for CMV D+/R- adult liver transplant…
2022 American Transplant Congress
Delayed Graft Function in Kidney Transplant Recipients is Associated with an Increased Risk f Post-Transplant Infections
V. Manchala, B. Muth, E. Yousif, J. Turk, J. Blazel, M. Bloom, N. Garg, F. Aziz, M. Mohamed, A. Djamali, D. Mandelbrot, B. Astor, S. Parajuli
UWSMPH, Madison, WI
*Purpose: Delayed graft function (DGF) is a known complication among kidney transplant recipients (KTRs) and is associated with decreased graft survival, increased rejection, and increased…
2022 American Transplant Congress
Outcome of Donor Derived and Community Acquired West Nile Infections in Kidney Transplant Recipients
R. K. Thimmisetty¹, G. Larrieux², S. Wilson², F. Barrantes¹, S. Kundeling¹, J. Kumar¹
¹Renal Medicine Associates, Albuquerque, NM, ²Presbyterian Health Services, Albuquerque, NM
*Purpose: Donor derived West Nile Virus(WNV) Infections can occur but rare. We are presenting four cases that were seen at our transplant center*Methods: Case 1:…
2022 American Transplant Congress
Use of Kidneys from Hepatitis C Nat Positive Donors for Uninfected Recipients: Early Results from a Rural Appalachian Kidney Transplant Program
B. Gillis¹, F. Afridi¹, R. Lopez¹, V. Chaudhary¹, D. Kannabhiran¹, C. Fagella¹, R. Zomak¹, K. Meyer¹, M. Thornberg¹, L. Biondi²
¹Department of Surgery, West Virginia University, Morgantown, WV, ²Department of Surgery, West Virginia University, Morgantown, WV, WV
*Purpose: Increasing mismatch between kidneys available for transplant and the number of patients on the transplant wait list has led to research into novel sources…
2022 American Transplant Congress
Evaluation of GLP-1 Receptor Agonist Use in the Solid Organ Transplant Population
S. E. Lawrence, M. R. Norvell, K. Schwarz, B. Crowther, P. Klem
Pharmacy, University of Colorado Hospital, Aurora, CO
*Purpose: The purpose of this study was to evaluate the utilization of and identify opportunities to optimize the use of glucagon-like peptide-1 receptor agonist (GLP-1…